Literature DB >> 12202753

The switch region on Leishmania major chromosome 1 is not required for mitotic stability or gene expression, but appears to be essential.

Pascal Dubessay1, Christophe Ravel, Patrick Bastien, Lucien Crobu, Jean-Pierre Dedet, Michel Pagès, Christine Blaineau.   

Abstract

The Leishmania genome project reference strain, Leishmania major Friedlin, is trisomic for chromosome 1. The complete sequence of this chromosome has revealed that the genes are grouped into two large clusters of the polycistronic type, each borne by one DNA strand and located on each side of a 1.6-kb sequence often termed the switch region. Several hypotheses concerning the role of this switch region have been put forward (region of initiation of transcription for both gene clusters, origin of replication or centromeric sequence). In the present study, we have deleted this region on the three copies of chromosome 1 by sequential targeted replacements. The absence of the switch region did not alter the mitotic stability of the three deleted chromosomes. This region therefore does not appear necessary for chromosomal replication or segregation. However, during the third targeting round, which aimed at knocking out the last switch region, a fourth copy of chromosome 1 that retained this region appeared in all clones analysed. This suggests that the persistence of this switch region is necessary for parasite survival. We then showed that the presence/absence of the switch region did not act upon the expression of a resistance marker gene inserted beforehand into the left gene cluster of the same chromosomal molecule. This result suggests that the presence of this 1.6-kb sequence is not necessary for the expression of all genes on chromosome 1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202753      PMCID: PMC137432          DOI: 10.1093/nar/gkf510

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  22 in total

1.  Effect of large targeted deletions on the mitotic stability of an extra chromosome mediating drug resistance in Leishmania.

Authors:  P Dubessay; C Ravel; P Bastien; M F Lignon; B Ullman; M Pagès; C Blaineau
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

2.  Mitotic stability of a coding DNA sequence-free version of Leishmania major chromosome 1 generated by targeted chromosome fragmentation.

Authors:  Pascal Dubessay; Christophe Ravel; Patrick Bastien; Ken Stuart; Jean-Pierre Dedet; Christine Blaineau; Michel Pagès
Journal:  Gene       Date:  2002-05-01       Impact factor: 3.688

3.  An expanding universe of noncoding RNAs.

Authors:  Gisela Storz
Journal:  Science       Date:  2002-05-17       Impact factor: 47.728

4.  Activation of silent replication origins at autonomously replicating sequence elements near the HML locus in budding yeast.

Authors:  M Vujcic; C A Miller; D Kowalski
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

5.  The ble resistance gene as a new selectable marker for Trypanosoma brucei: fly transmission of stable procyclic transformants to produce antibiotic resistant bloodstream forms.

Authors:  D Jefferies; P Tebabi; D Le Ray; E Pays
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

6.  The effect on chromosome stability of deleting replication origins.

Authors:  A Dershowitz; C S Newlon
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

7.  The size difference between leishmania major friedlin chromosome one homologues is localized to sub-telomeric repeats at one chromosomal end.

Authors:  S M Sunkin; P Kiser; P J Myler; K Stuart
Journal:  Mol Biochem Parasitol       Date:  2000-06       Impact factor: 1.759

8.  The Leishmania genome project: new insights into gene organization and function.

Authors:  P J Myler; S M Beverley; A K Cruz; D E Dobson; A C Ivens; P D McDonagh; R Madhubala; S Martinez-Calvillo; J C Ruiz; A Saxena; E Sisk; S M Sunkin; E Worthey; S Yan; K D Stuart
Journal:  Med Microbiol Immunol       Date:  2001-11       Impact factor: 3.402

9.  The Leishmania genome comprises 36 chromosomes conserved across widely divergent human pathogenic species.

Authors:  P Wincker; C Ravel; C Blaineau; M Pages; Y Jauffret; J P Dedet; P Bastien
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

10.  Plasticity in chromosome number and testing of essential genes in Leishmania by targeting.

Authors:  A K Cruz; R Titus; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

View more
  6 in total

1.  Leishmania major chromosome 3 contains two long convergent polycistronic gene clusters separated by a tRNA gene.

Authors:  E A Worthey; Santiago Martinez-Calvillo; Achim Schnaufer; Gautam Aggarwal; Jason Cawthra; Gholam Fazelinia; Chris Fong; Guoliang Fu; Melissa Hassebrock; Greg Hixson; Alasdair C Ivens; Patti Kiser; Felicia Marsolini; Erika Rickel; Erica Rickell; Reza Salavati; Ellen Sisk; Susan M Sunkin; Kenneth D Stuart; Peter J Myler
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

2.  Spliced leader RNA gene transcription in Trypanosoma brucei requires transcription factor TFIIH.

Authors:  Ju Huck Lee; Tu N Nguyen; Bernd Schimanski; Arthur Günzl
Journal:  Eukaryot Cell       Date:  2007-01-26

3.  The genetic toolbox for Leishmania parasites.

Authors:  Sigrid C Roberts
Journal:  Bioeng Bugs       Date:  2011-11-01

Review 4.  Cell biology of the trypanosome genome.

Authors:  Jan-Peter Daniels; Keith Gull; Bill Wickstead
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

5.  Compared genomics of the strand switch region of Leishmania chromosome 1 reveal a novel genus-specific gene and conserved structural features and sequence motifs.

Authors:  Jacques Puechberty; Christine Blaineau; Sabrina Meghamla; Lucien Crobu; Michel Pagès; Patrick Bastien
Journal:  BMC Genomics       Date:  2007-02-24       Impact factor: 3.969

Review 6.  Challenges and Tools for In Vitro Leishmania Exploratory Screening in the Drug Development Process: An Updated Review.

Authors:  Anita Cohen; Nadine Azas
Journal:  Pathogens       Date:  2021-12-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.